Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$35.55 - $43.57 $103 Million - $126 Million
-2,895,950 Reduced 66.14%
1,482,769 $64.4 Million
Q3 2023

Nov 14, 2023

BUY
$39.13 - $47.24 $171 Million - $207 Million
4,378,418 Added 1454623.88%
4,378,719 $177 Million
Q2 2023

Aug 14, 2023

SELL
$43.93 - $46.76 $4.52 Million - $4.81 Million
-102,781 Reduced 99.71%
301 $13,000
Q1 2023

May 15, 2023

SELL
$45.29 - $50.76 $4.98 Million - $5.58 Million
-109,910 Reduced 51.6%
103,082 $4.73 Million
Q4 2022

Feb 14, 2023

BUY
$41.91 - $50.48 $8.93 Million - $10.8 Million
212,992 New
212,992 $10.6 Million
Q2 2022

Aug 15, 2022

BUY
$42.98 - $49.77 $1.93 Million - $2.24 Million
45,000 Added 10.81%
461,300 $21.8 Million
Q1 2022

May 16, 2022

BUY
$42.23 - $54.3 $13.6 Million - $17.5 Million
322,900 Added 345.72%
416,300 $20.4 Million
Q4 2021

Feb 14, 2022

BUY
$50.62 - $56.47 $278,410 - $310,585
5,500 Added 6.26%
93,400 $5.19 Million
Q3 2021

Nov 15, 2021

BUY
$46.55 - $56.83 $4.09 Million - $5 Million
87,900 New
87,900 $4.54 Million
Q4 2019

Feb 14, 2020

SELL
$25.41 - $43.1 $4.36 Million - $7.39 Million
-171,532 Closed
0 $0
Q3 2019

Nov 15, 2019

BUY
$32.73 - $40.81 $5.24 Million - $6.53 Million
159,988 Added 1385.9%
171,532 $5.66 Million
Q2 2019

Aug 14, 2019

BUY
$35.73 - $41.39 $412,467 - $477,806
11,544 New
11,544 $468,000
Q2 2018

Aug 14, 2018

SELL
$31.23 - $37.47 $203,463 - $244,117
-6,515 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$31.01 - $34.72 $6.72 Million - $7.52 Million
-216,600 Reduced 97.08%
6,515 $210,000
Q4 2017

Feb 14, 2018

BUY
$30.68 - $35.37 $5.77 Million - $6.65 Million
188,115 Added 537.47%
223,115 $6.9 Million
Q3 2017

Nov 14, 2017

BUY
$31.02 - $32.94 $1.09 Million - $1.15 Million
35,000
35,000 $1.1 Million

Others Institutions Holding QGEN

About QIAGEN N.V.


  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $10.5B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.